The White House stated, “These agreements are projected to save Americans more than $600 billion.“ President Donald Trump extended Most Favored Nation pricing to prescription drugs under every Medicaid…
Read MoreDiabetes
State Department Issues New Guidance on Inadmissible Health Conditions for Visas
Chronic health issues such as obesity, diabetes, and other diseases will be considered under the public charge risk. The State Department released new guidance on the health conditions…
Read More
President Announces Obesity Drug Deal with Pharmaceutical Companies
The most recent development would greatly reduce the cost under the president’s Most Favored Nation prescription drug pricing policy. President Donald Trump announced that a deal has been…
Read More
FDA Launches Voucher Program to Accelerate Priority Review of Drugs
Nine products selected under the pilot initiative are intended to address major health needs and boost U.S. manufacturing. The U.S. Food and Drug Administration has recently named nine…
Read More
FTC Challenges Drug Patents Hindering Generic Competition
The agency renewed efforts to remove over 200 disputed patents from FDA’s Orange Book to promote affordable medication access. The Federal Trade Commission (FTC) recently renewed its challenge…
Read More
Federal Court Rules in Favor of Generic Drug Competition in Patent Case
The court orders the removal of improper patent listings, clearing the path for lower-cost medications. The Federal Circuit U.S. Court of Appeals recently upheld a lower court’s decision…
Read More
HHS Reports Lower Medicare Prices on 10 Drugs
The deal is expected to save billions for Medicare and reduce out-of-pocket costs for millions of seniors starting in 2026. The Department of Health and Human Services (HHS)…
Read More
U.S. Representative Donald Payne, Jr., Passes Away at 65
House Speaker Johnson offers prayers for the congressman’s loved ones. U.S. Congressman Donald M. Payne, Jr., of New Jersey, passed away on Wednesday after a heart attack two…
Read More
FDA Approves Medication for Liver Scarring
The medication was fast-tracked through the agency’s accelerated approval pathway. The U.S. Food and Drug Administration (FDA) has authorized Rezdiffra (resmetirom) for adults experiencing noncirrhotic non-alcoholic steatohepatitis (NASH),…
Read More
FDA Approves Wegovy for Cardiovascular Risk Reduction
The injection becomes the first weight loss medication to address life-threatening cardiovascular events. The Food and Drug Administration has expanded the approved use of Wegovy (semaglutide) injection, making…
Read More